A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma

GÜNDOĞ, METE; BAŞARAN, HATİCE; BOZKURT, OKTAY; EROĞLU, CELALETTİN

doi:10.1016/j.bjorl.2019.04.008

A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma

GÜNDOĞ M., BAŞARAN H., BOZKURT O., EROĞLU C.

BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, cilt.86, sa.6, ss.676-686, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 86 Sayı: 6
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.bjorl.2019.04.008
Dergi Adı: BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
Sayfa Sayıları: ss.676-686
Anahtar Kelimeler: Cumulative cisplatin dose, Chemotherapy schedule, Nasopharyngeal carcinoma
Erciyes Üniversitesi Adresli: Evet

Özet

Introduction: Three-weekly cisplatin dose is accepted for standard treatment for concurrent chemo-radiotherapy in nasopharyngeal carcinoma. However, different chemotherapy schedules are presented in the literature.